ArticleCancer research communications2025

Phase Ib Study of Immunocytokine Simlukafusp Alfa (FAP-IL2v) Combined with Pembrolizumab for Treatment of Advanced and/or Metastatic Melanoma.

Eva Munoz-Couselo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.